Cancer Therapy News and Research

RSS

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

The Detroit Lions and Josephine Ford Cancer Institute, Michigan's largest provider of adult cancer care, have created a unique partnership with the goal to raise $15 million during the next three years for cancer research in metro Detroit.

16 Oct 2013

Astrazeneca Acquires Spirogen For Up To $440M

...

15 Oct 2013

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Crown Bioscience, Inc., a leading global drug discovery and development service company, today announces that it has entered into a collaboration with Xstrahl Ltd, a leading designer and manufacturer of X-Ray solutions for radiation biology research.

From Xstrahl 15 Oct 2013

Promising new type of cancer treatment to benefit more patients

More patients than ever stand to benefit from a promising new type of cancer treatment, after scientists compiled a library of molecules that can prime patients’ immune systems to fight a range of cancers including leukaemia, myeloma, lung cancer and skin cancer.

15 Oct 2013

DIM compound derived from cruciferous vegetable protects rodents from radiation doses

Georgetown University Medical Center researchers say a compound derived from cruciferous vegetable such as cabbage, cauliflower and broccoli protected rats and mice from lethal doses of radiation.

15 Oct 2013

Scientists discover genetic mutation associated with low-risk bladder cancer

An international research team led by scientists from Georgetown Lombardi Comprehensive Cancer Center has discovered a genetic mutation linked to low-risk bladder cancer.

13 Oct 2013

Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

...

11 Oct 2013

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

For childhood cancer survivors, risk factors associated with lifestyle, particularly hypertension, dramatically increase the likelihood of developing serious heart problems as adults, according to a national study led by St. Jude Children's Research Hospital. The findings appear in the current issue of the Journal of Clinical Oncology.

11 Oct 2013

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.

9 Oct 2013

CNIO researcher identifies new molecular mechanism that regulates genome stability, cell proliferation

Cell division is an essential process for the development of an organism. This process, however, can cause tumour growth when it stops working properly. Tumour cells accumulate alterations in their genetic material, and this makes them divide in an uncontrolled fashion, thus encouraging growth of the tumour.

9 Oct 2013

Mitsubishi Electric to provide proton beam therapy system to Hakuhokai Group healthcare organization

Mitsubishi Electric Corporation announced today that it will provide its innovative proton beam therapy system for cancer treatment to the Hakuhokai Group healthcare organization led by Chairman Motohisa Kojo in Osaka, Japan. The system will be installed at the Hakuhokai Group Osaka Proton Therapy Clinic scheduled to open in April 2016.

9 Oct 2013

UNM School of Medicine recruited two new hires for Department of Surgery

The Surgical Oncology Department of the University of New Mexico Cancer Center is growing even larger. Ashwani Rajput, MD, Chief of the Division of Surgical Oncology in the Department of Surgery at the UNM School of Medicine, has recently recruited two new hires for the department. Bridget Fahy, MD, who specializes in colorectal and complex pelvic cancer, and Anna Voltura, MD, who specializes in breast cancer, are both excited about the opportunity to work in an NCI designated cancer center.

8 Oct 2013

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Immutep S.A., the biopharmaceutical company specializing in immuno-oncology, and Eddingpharm have entered into an agreement regarding the development, commercialization and manufacturing of Immutep’s ImmuFact IMP321.

7 Oct 2013

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.

7 Oct 2013

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that a Services Agreement has been signed with the German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen (GRCBDS) whereby GRCBDS will provide pharmaceutical development and GMP manufacturing services for Kiadis Pharma's ongoing Phase II clinical study with ATIR™.

7 Oct 2013

Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS

Last night Honorary Fellowship in the American College of Surgeons (ACS) was awarded to six prominent surgeons from Germany, England, Thailand, Mexico, and Malaysia during the Convocation ceremony that preceded the official opening of the 2013 Clinical Congress of the American College of Surgeons.

7 Oct 2013

Opinions on shutdown: Both sides have moved to indefensible positions; health law is not 'settled,' finding a 'non-disastrous' debt deal

Acrimony, insults, the government shut down. Time to talk to a wise man, someone from the days when government worked. I turned to the famous Mr. Baker - James A. Baker III. ... The Republicans made a mistake early on with a "maximalist" position on Obamacare - they could not realistically achieve their aim of defunding when the Democrats hold the White House and Senate. But the president's position is a "pretty damn maximalist position itself, and people will say that" (Peggy Noonan, 10/3).

5 Oct 2013

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

5 Oct 2013

Dying heart cells are kept alive with spikes of oxygen

In a study published in published in EMBO Molecular Medicine, a Dartmouth researcher found that dying heart cells are kept alive with spikes of oxygen.

5 Oct 2013

Cynvenio launches ClearID Breast Cancer monitoring program

Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.

4 Oct 2013

Cancer Therapy News and Research

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

Astrazeneca Acquires Spirogen For Up To $440M

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Promising new type of cancer treatment to benefit more patients

DIM compound derived from cruciferous vegetable protects rodents from radiation doses

Scientists discover genetic mutation associated with low-risk bladder cancer

Astrazeneca, Janssen To Promote Novel Prostate Cancer Treatment In Japan

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

Gemcitabine drug improves survival rates in patients with pancreatic cancer

CNIO researcher identifies new molecular mechanism that regulates genome stability, cell proliferation

Mitsubishi Electric to provide proton beam therapy system to Hakuhokai Group healthcare organization

UNM School of Medicine recruited two new hires for Department of Surgery

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS

Opinions on shutdown: Both sides have moved to indefensible positions; health law is not 'settled,' finding a 'non-disastrous' debt deal

New technique for breast cancer treatment and prevention-injection via nipple

Dying heart cells are kept alive with spikes of oxygen

Cynvenio launches ClearID Breast Cancer monitoring program

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News